+关注
fzw123
暂无个人介绍
IP属地：北京
21
关注
0
粉丝
0
主题
0
勋章
主贴
热门
fzw123
08-13
流氓，枉我五年持有
抱歉，原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3483040284413532","uuid":"3483040284413532","gmtCreate":1519946263956,"gmtModify":1519946263956,"name":"fzw123","pinyin":"fzw123","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":21,"tweetSize":1,"questionSize":0,"limitLevel":900,"accountStatus":3,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":467068307415224,"gmtCreate":1755047284117,"gmtModify":1755048403209,"author":{"id":"3483040284413532","authorId":"3483040284413532","name":"fzw123","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3483040284413532","idStr":"3483040284413532"},"themes":[],"htmlText":"流氓，枉我五年持有","listText":"流氓，枉我五年持有","text":"流氓，枉我五年持有","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/467068307415224","repostId":"2558640660","repostType":2,"isVote":1,"tweetType":1,"viewCount":249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":467068307415224,"gmtCreate":1755047284117,"gmtModify":1755048403209,"author":{"id":"3483040284413532","authorId":"3483040284413532","name":"fzw123","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3483040284413532","authorIdStr":"3483040284413532"},"themes":[],"htmlText":"流氓，枉我五年持有","listText":"流氓，枉我五年持有","text":"流氓，枉我五年持有","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/467068307415224","repostId":"2558640660","repostType":2,"repost":{"id":"2558640660","kind":"news","pubTimestamp":1755007422,"share":"https://www.laohu8.com/m/news/2558640660?lang=&edition=full","pubTime":"2025-08-12 22:03","market":"fut","language":"zh","title":"康基医疗(09997)获溢价约9.9%提私有化","url":"https://stock-news.laohu8.com/highlight/detail?id=2558640660","media":"智通财经","summary":"智通财经APP讯，康基医疗 及要约人Knight Bidco Limited联合公布，于2025年7月17日，要约人要求董事会向股东提呈该建议，内容有关建议根据公司法第86条以协议安排方式将该公司私有化。于该建议完成后，该公司将成为要约人的全资附属公司，而股份于联交所的上市地位将被撤销。根据该计划，计划股份将被注销，而计划股东将就每股计划股份获得现金9.25港元，注销价格9.25港元较股份于最后交易日在联交所所报的收市价每股8.42港元溢价约9.9%。","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/09997\">康基医疗</a>(09997)及要约人Knight Bidco Limited联合公布，于2025年7月17日，要约人要求董事会向股东提呈该建议，内容有关建议根据公司法第86条以协议安排方式将该公司私有化。于该建议完成后，该公司将成为要约人的全资附属公司，而股份于联交所的上市地位将被撤销。</p><p>在满足先决条件后，该建议将通过该计划实施。根据该计划，计划股份将被注销，而计划股东(不包括创始人计划股份及TPG计划股份的持有人)将就每股计划股份获得现金9.25港元，注销价格9.25港元较股份于最后交易日在联交所所报的收市价每股8.42港元溢价约9.9%。</p><p>于公告日期，要约人由MidCo全资拥有，而MidCo由TopCo全资拥有。于本公告日期，TopCo由财团成员持有，其中Fortune Spring ZM、Fortune Spring YG、TPG Asia VII、Keyhole、Knight Success、NewQuest V及Al-Rayyan Holding分别持有约25.53%、约14.47%、约24.38%、约5.01%、约5.69%、约4.56%及约20.36%。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康基医疗(09997)获溢价约9.9%提私有化</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康基医疗(09997)获溢价约9.9%提私有化\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-12 22:03 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/1328774.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，康基医疗(09997)及要约人Knight Bidco Limited联合公布，于2025年7月17日，要约人要求董事会向股东提呈该建议，内容有关建议根据公司法第86条以协议安排方式将该公司私有化。于该建议完成后，该公司将成为要约人的全资附属公司，而股份于联交所的上市地位将被撤销。在满足先决条件后，该建议将通过该计划实施。根据该计划，计划股份将被注销，而计划股东(不包括创始人计划...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1328774.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09997":"康基医疗","BK1583":"高瓴概念","BK1222":"医疗保健用品"},"source_url":"http://www.zhitongcaijing.com/content/detail/1328774.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2558640660","content_text":"智通财经APP讯，康基医疗(09997)及要约人Knight Bidco Limited联合公布，于2025年7月17日，要约人要求董事会向股东提呈该建议，内容有关建议根据公司法第86条以协议安排方式将该公司私有化。于该建议完成后，该公司将成为要约人的全资附属公司，而股份于联交所的上市地位将被撤销。在满足先决条件后，该建议将通过该计划实施。根据该计划，计划股份将被注销，而计划股东(不包括创始人计划股份及TPG计划股份的持有人)将就每股计划股份获得现金9.25港元，注销价格9.25港元较股份于最后交易日在联交所所报的收市价每股8.42港元溢价约9.9%。于公告日期，要约人由MidCo全资拥有，而MidCo由TopCo全资拥有。于本公告日期，TopCo由财团成员持有，其中Fortune Spring ZM、Fortune Spring YG、TPG Asia VII、Keyhole、Knight Success、NewQuest V及Al-Rayyan Holding分别持有约25.53%、约14.47%、约24.38%、约5.01%、约5.69%、约4.56%及约20.36%。","news_type":1,"symbols_score_info":{"09997":1}},"isVote":1,"tweetType":1,"viewCount":249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
